Emil Hagström

26PUBLICATIONS
130CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsEnvironmental epidemiologySystems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 08, 2026
Determinants of risk factor target attainment after myocardial infarction: the Perfect-CR study.

|Mar 28, 2026
Methodological Challenges of Emulating a Target Trial to Assess Effectiveness of Timing of PCSK9 Inhibitor Treatment Initiation Post Myocardial Infarction.

Thomas Cars, Stefan Gustafsson, Queenie Chan

|Feb 19, 2026
Triglyceride reduction after MI and major adverse outcomes in SWEDEHEART-insights for future trials.

Jessica Schubert, Emil Hagström, Johan Westerbergh

|Nov 13, 2025
Double the measures-double the benefit: Kidney Disease Screening in Coronary Heart Disease.

Margret Leosdottir, Anders Christensson, Emil Hagström

|Nov 07, 2025
Plasma Protein Profile Associated With a Family History of Early-Onset Coronary Heart Disease.

Agnes Wahrenberg, Lars Lind, Natan Åberg

|Nov 04, 2025
Utilization and discontinuation of secondary prevention pharmacotherapy after myocardial infarction: a nationwide cohort study.

Ali Yari, Carl-Emil Lim, Emil Hagström

Pageof 5

Frequent Collaborators

5 joint publications

Tomas Jernberg

5 joint publications

Margret Leosdottir

4 joint publications

Claes Held

4 joint publications

Jessica Schubert